you're supposed to go up when your phase III study is successful...not down.
Here is the reason TSRX went down today on big volume:http://www.rib-x.com/investors/press-release_2011_12_15.phpRib-X's competing antibiotic's Phase II MRSA results were SUPERIOR.
do u know when RIB-X is debuting in their IPO? thanx.
Do people actually do their own analysis anymore? Rib-x's 48-72 efficacy is 78% and trius' is 79%. Trius' antibiotic is once a day while Rib-x's twice daily. In addition, the reason why Trius' drug looks less efficacious is because zyvox in their trial is 79% versus a Rid-x efficacy of 74.7%. Do you own analysis and make up your own mind despite what wall street says.